FDA and CDC Lift Pause on J&J COVID-19 Vaccine

After a safety review today, the FDA and CDC lifted the pause on the Johnson & Johnson COVID-19 vaccine. See the full announcement on the FDA website.

CDC and FDA Recommend Pause of Johnson & Johnson Vaccine

The CDC and FDA issued a joint statement about pausing the Johnson & Johnson Covid-19 vaccine on April 13, 2021 because of concerns about rare but serious blood clots associated with it. See the FDA YouTube below for more information. There will be a meeting today of the Advisory Committee on Immunization Practices (ACIP) to review the cases and assess further significance. The Iowa Department of Public Health has recommended that all agencies pause administration of the Johnson & Johnson vaccine. The recommendation is being followed, comments by University of Iowa Health Care experts are reported in the Daily Iowan. The CDC has posted a Health Alert Network notice.

%d bloggers like this: